Yehudit Abrams, MD, a former NASA biomedical scientist, is planning to develop a handheld ultrasound device that will allow women to monitor their breasts in their homes, according to a July 15 report by The Times of Israel.

R. Rex Parris, the mayor of Lancaster, California, has proposed the city ban local employees from being required to wear a necktie. The decision, he said, was made after reading about recent imaging research that found neckties can lead to a reduction in cerebral blood flow.

Failure-to-communicate lawsuits are on the rise among radiologists, according to an editorial published in the Journal of the American College of Radiology this month, leaving legal lines of the specialization blurry.

The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.

After work requirements for eligible Medicaid beneficiaries too effect in Arkansas, more than 7,000 people failed to report they worked at least 80 hours in June.

GE Healthcare is launching OmnipaqueTM (iohexol) Oral Solution in the United States, a new, ready-to-drink contrast medium that can be used to help physicians diagnose medical conditions by improving the diagnostic visualization of the abdominal gastrointestinal tract.

U.S. antitrust enforcers might not move to block CVS Health’s acquisition of health insurance company Aetna, Bloomberg reported.

Radiologists have a lot to be excited about in 2018 and beyond. Jim Y. Chen, MD, of the department of radiology at Brigham and Women’s Hospital in Boston, explored some recent statistics in a new commentary published by the Journal of the American College of Radiology, detailing what they mean for the specialty this year and in years ahead.

KALAMAZOO, Michigan, USA, July 16, 2018 — Stryker Corporation announced today that the U.S. Food and Drug Administration has granted pre-market approval (PMA) for the Surpass Streamline Flow Diverter to treat unruptured large and giant wide neck intracranial aneurysms. The device is the second flow diverting stent to gain FDA approval in the U.S.

The Department of Veterans Affairs recently named Genevieve Morris, the principal deputy national coordinator for HHS, as the leader of the Office of Electronic Health Record Modernization (OEHRM). The VA announced the decision July 12.